Work

Phase Ib/II trial of gemcitabine, cisplatin, plus lenalidomide as first-line therapy for patients with metastatic urothelial carcinoma.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.4_suppl.321

Authors: Che-Kai Tsao, Neeraj Agarwal, Andrea Borghese Apolo, Karen M Lee, James H. Godbold, William K. Oh, Matt D. Galsky

Institutions: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, University of Utah, Huntsman Cancer Institute, National Institutes of Health, National Cancer Institute

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589942304

Cites:

Cited by:

Related to: 10